Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma
Clinical trial NCT00477815 · COMPLETED
Trial details
- NCT number
- NCT00477815
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-31
- Primary completion
- 2011-07-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.